Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
02 2021
Historique:
received: 23 10 2020
revised: 13 11 2020
accepted: 20 11 2020
pubmed: 11 12 2020
medline: 2 7 2021
entrez: 10 12 2020
Statut: ppublish

Résumé

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous condition, and tissue congestion manifested by oedema is not present in all patients. We compared clinical characteristics, exercise capacity, and outcomes in patients with HFpEF with and without oedema. This study was a post hoc analysis of pooled data of patients with left ventricular ejection fraction of ≥50% enrolled in the DOSE, CARRESS-HF, RELAX, ATHENA, ROSE, INDIE, and NEAT trials. Patients were dichotomized by the severity of oedema. Cox proportional hazard regression and generalized linear regression models were used to assess associations between oedema, symptoms, and clinical outcomes. The ambulatory cohort included 393 patients (228 with and 165 without oedema), and the hospitalized cohort included 338 patients (249 with ≥moderate oedema and 89 with mild or none). Among ambulatory patients, patients with oedema had a higher body mass index (35.2 kg/m Patients with HFpEF and oedema display higher body mass, greater burden of co-morbidities, and more severe exercise intolerance, but clinical responses to treatment appear similar. Further research is required to better understand the nature of volume distribution in different HFpEF phenotypes.

Identifiants

pubmed: 33300277
doi: 10.1002/ehf2.13159
pmc: PMC7835593
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

662-669

Subventions

Organisme : NHLBI NIH HHS
ID : U10 HL110309
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL079896
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110342
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110262
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110338
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110302
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL084904
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110336
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110337
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110312
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL110297
Pays : United States

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Card Fail. 2020 Feb;26(2):112-117
pubmed: 31568830
N Engl J Med. 2015 Dec 10;373(24):2314-24
pubmed: 26549714
Mayo Clin Proc. 2019 Jul;94(7):1199-1209
pubmed: 31272568
Circ Heart Fail. 2014 Jan;7(1):76-87
pubmed: 24281134
JAMA Cardiol. 2017 Sep 1;2(9):950-958
pubmed: 28700781
N Engl J Med. 2011 Mar 3;364(9):797-805
pubmed: 21366472
JAMA. 2013 Dec 18;310(23):2533-43
pubmed: 24247300
N Engl J Med. 2012 Dec 13;367(24):2296-304
pubmed: 23131078
Eur J Heart Fail. 2005 Oct;7(6):953-7
pubmed: 16227134
Eur Heart J Acute Cardiovasc Care. 2018 Jun;7(4):330-338
pubmed: 28139135
ESC Heart Fail. 2021 Feb;8(1):662-669
pubmed: 33300277
JAMA. 2013 Mar 27;309(12):1268-77
pubmed: 23478662
JACC Heart Fail. 2017 Jan;5(1):1-13
pubmed: 28034373
Circulation. 2007 Oct 2;116(14):1549-54
pubmed: 17846286
JACC Heart Fail. 2020 Mar;8(3):172-184
pubmed: 31926856
Int J Cardiol. 2019 Jun 15;285:40-46
pubmed: 30905515
JAMA. 2018 Nov 6;320(17):1764-1773
pubmed: 30398602
J Am Heart Assoc. 2017 Aug 17;6(8):
pubmed: 28862947
Circ Heart Fail. 2016 Aug;9(8):e002922
pubmed: 27436837
Circ Heart Fail. 2010 Sep;3(5):588-95
pubmed: 20543134

Auteurs

Marat Fudim (M)

Department of Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27713, USA.

Nicolas Ashur (N)

Department of Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27713, USA.

Aaron D Jones (AD)

Duke Clinical Research Institute, Durham, NC, USA.

Andrew P Ambrosy (AP)

Kaiser Permanente, San Francisco, CA, USA.

Bradley A Bart (BA)

Minneapolis VA Medical Center, Minneapolis, MN, USA.

Javed Butler (J)

Department of Medicine, University of Mississippi, Jackson, MS, USA.

Horng H Chen (HH)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Stephen J Greene (SJ)

Department of Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27713, USA.

Yogesh Reddy (Y)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Margaret M Redfield (MM)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Abhinav Sharma (A)

Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.

Adrian F Hernandez (AF)

Department of Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27713, USA.
Duke Clinical Research Institute, Durham, NC, USA.

Gary Michael Felker (GM)

Department of Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27713, USA.
Duke Clinical Research Institute, Durham, NC, USA.

Barry A Borlaug (BA)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Robert J Mentz (RJ)

Department of Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27713, USA.
Duke Clinical Research Institute, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH